202 related articles for article (PubMed ID: 2966574)
1. Plasma concentrations of immunoreactive atrial natriuretic peptide in hospitalized cirrhotic and noncirrhotic patients: evidence for a role of deficient atrial natriuretic peptide in pathogenesis of cirrhotic ascites.
Bonkovsky HL; Hartle DK; Mellen BG; Kutner M; Galambos JT
Am J Gastroenterol; 1988 May; 83(5):531-5. PubMed ID: 2966574
[TBL] [Abstract][Full Text] [Related]
2. Plasma endothelin levels in cirrhotic patients and their correlation with atrial natriuretic peptide.
Chen YX; Wang SC; Zhao GN; Tang J; Zhang SX; Tang CS
Chin Med J (Engl); 1993 Sep; 106(9):643-6. PubMed ID: 8287696
[TBL] [Abstract][Full Text] [Related]
3. Interrelationship between atrial natriuretic peptide and plasma renin, aldosterone and catecholamines in hepatic cirrhosis: the effect of passive leg rising.
Burghardt W; Müller R; Diehl KL; Wernze H
Z Kardiol; 1988; 77 Suppl 2():104-10. PubMed ID: 2970163
[TBL] [Abstract][Full Text] [Related]
4. Molecular forms and biological activity of atrial natriuretic factor in patients with cirrhosis and ascites.
Jiménez W; Gutkowska J; Ginés P; Arroyo V; Rivera F; Rodés J
Hepatology; 1991 Oct; 14(4 Pt 1):601-7. PubMed ID: 1833302
[TBL] [Abstract][Full Text] [Related]
5. Atrial natriuretic peptide in hepatic cirrhosis: relation to stage of disease, sympathoadrenal system and renin-aldosterone axis.
Burghardt W; Wernze H; Diehl KL
Klin Wochenschr; 1986; 64 Suppl 6():103-7. PubMed ID: 2948055
[TBL] [Abstract][Full Text] [Related]
6. Plasma levels of atrial natriuretic peptide in compensated and decompensated cirrhosis of the liver. Relationship with the renin-aldosterone system.
Colantonio D; Casale R; Pasqualetti P
Panminerva Med; 1989; 31(4):166-70. PubMed ID: 2534427
[TBL] [Abstract][Full Text] [Related]
7. Refractory ascites in cirrhosis: roles of volume expansion and plasma atrial natriuretic factor level elevation.
Wong F; Tobe S; Legault L; Logan AG; Skorecki K; Blendis LM
Hepatology; 1993 Sep; 18(3):519-28. PubMed ID: 8395457
[TBL] [Abstract][Full Text] [Related]
8. [Increase in absolute atmospheric pressure in hyperbaric chamber in cirrhosis with ascites: lack of natriuretic response and increase of atrial natriuretic peptide].
Gambini G; Fioroni E; Guerra M; Moscatelli A; Valori C
Minerva Med; 1994 Mar; 85(3):77-81. PubMed ID: 8196847
[TBL] [Abstract][Full Text] [Related]
9. [ANP in the cirrhotic patient. A clinical contribution].
Parlapiano C; Labellarte A; Primi F; Cervellini P; La Torre F; Paparo SB; Baccarini S; Di Nardo A
Minerva Endocrinol; 1994 Sep; 19(3):121-6. PubMed ID: 7799893
[TBL] [Abstract][Full Text] [Related]
10. Cardiovascular and renal effects of low-dose atrial natriuretic peptide in compensated cirrhosis.
La Villa G; Lazzeri C; Pascale A; Sestini S; Bisi G; Sciagrà R; Vecchiarino S; Raggi VC; Barletta G; Laffi G; Gentilini P
Am J Gastroenterol; 1997 May; 92(5):852-7. PubMed ID: 9149200
[TBL] [Abstract][Full Text] [Related]
11. Urinary excretion of urodilatin in patients with cirrhosis.
Saló J; Jiménez W; Kuhn M; Ginès A; Ginès P; Fernández-Esparrach G; Angeli P; Clària J; Bataller R; Arroyo V; Forssmann WG; Rodés J
Hepatology; 1996 Dec; 24(6):1428-32. PubMed ID: 8938175
[TBL] [Abstract][Full Text] [Related]
12. Serum endothelin and atrial natriuretic peptide in cirrhotic patients with ascites and hepatorenal syndrome.
Lo GH; Lam HC; Cheng JT; Lin JK; Hsu JH; Lai KH; Chiang HT
Zhonghua Yi Xue Za Zhi (Taipei); 1998 Oct; 61(10):596-602. PubMed ID: 9830237
[TBL] [Abstract][Full Text] [Related]
13. [Pathophysiologic and clinical relevance of atrial natriuretic factor in patients with cirrhosis of the liver].
Gerbes AL; Arendt R; Xie Y; Knorr HJ; Riedel A; Paumgartner G
Z Kardiol; 1988; 77 Suppl 2():99-103. PubMed ID: 2970181
[TBL] [Abstract][Full Text] [Related]
14. High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: indirect evidence of reduced natriuretic effectiveness of the peptide.
Trevisani F; Colantoni A; Sica G; Gasbarrini A; D'Intino PE; De Notariis S; De Jaso R; Barbieri A; Morselli A; Gasbarrini G
Hepatology; 1995 Jul; 22(1):132-7. PubMed ID: 7601404
[TBL] [Abstract][Full Text] [Related]
15. Dendroaspis natriuretic peptide in hepatic cirrhosis.
Fábrega E; Crespo J; Rivero M; Casafont F; Castro B; García-Unzueta MT; Amado JA; Pons-Romero F
Am J Gastroenterol; 2001 Sep; 96(9):2724-9. PubMed ID: 11569702
[TBL] [Abstract][Full Text] [Related]
16. Brain natriuretic peptide: is it a predictor of cardiomyopathy in cirrhosis?
Wong F; Siu S; Liu P; Blendis LM
Clin Sci (Lond); 2001 Dec; 101(6):621-8. PubMed ID: 11724649
[TBL] [Abstract][Full Text] [Related]
17. Plasma levels of atrial natriuretic peptide in patients with chronic liver disease.
Kawasaki H; Uemasu J; Maeda N; Hirayama C; Kobayashi T; Sakurai H
Am J Gastroenterol; 1987 Aug; 82(8):727-31. PubMed ID: 3037881
[TBL] [Abstract][Full Text] [Related]
18. Atrial natriuretic peptide in patients with decompensated hepatic cirrhosis.
Tulassay T; Tulassay Z; Rascher W
Gastroenterol J; 1990; 50(3):140-3. PubMed ID: 2149634
[TBL] [Abstract][Full Text] [Related]
19. Correlation of nitric oxide and atrial natriuretic peptide changes with altered cGMP homeostasis in liver cirrhosis.
Montoliu C; Kosenko E; Del Olmo JA; Serra MA; Rodrigo JM; Felipo V
Liver Int; 2005 Aug; 25(4):787-95. PubMed ID: 15998430
[TBL] [Abstract][Full Text] [Related]
20. [Human atrial natriuretic factor (hANF) in liver cirrhosis].
Pidlich J; Müller C; Hartter E; Renner F; Klepetko W; Miholic J; Woloszczuk W
Acta Med Austriaca; 1987; 14(5):125-9. PubMed ID: 2964160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
